Andrew Brenner

Statistics

Publications

113

Citations

H-Index

Active since

1994

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

The University of Texas MD Anderson Cancer Center

The University of Texas at Austin

Mays Cancer Center at UT Health San Antonio

The University of Texas at San Antonio

Andrew Brenner is an author at The University of Texas at San Antonio Health Science Center specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1994–2025

113

Publications

113

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad et al. · British Journal of Cancer · 2020 · 912 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

Muhammad S. Beg, Andrew Brenner, Jasgit C. Sachdev et al. · Investigational New Drugs · 2016 · 884 citations · Full text

Medicine, Oncology, Pharmacology +8

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 540 citations · Full text

Medicine, Immunology, Oncology +17

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 405 citations · Full text

Medicine, Immunology, Oncology +17

First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors

Gerald S. Falchook, Jeffrey R. Infante, Hendrik‐Tobias Arkenau et al. · EClinicalMedicine · 2021 · 275 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 113